Clinical Trial Update: Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating Omegaven fish oil emulsion for parenteral nutrition-associated liver disease in infants and children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholestasis

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Kapiolani Medical Center For Women & Children | Conditions: Cholestasis | Phase 3 | Status: COMPLETED